Susquehanna International Group, LLP Astrazeneca PLC Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 555,242 shares of AZN stock, worth $40.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
555,242
Previous 106,659
420.58%
Holding current value
$40.9 Million
Previous $8.31 Million
337.77%
% of portfolio
0.01%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...